Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hermann E Wasmuth

Showing results (51-60 of 78) with videos related to

Pageof 8
Sort By:
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 6, 2011
A 7-gene signature of the recipient predicts the progression of fibrosis after liver transplantation for hepatitis C virus infectionNicole T do O, Dennis Eurich, Petra Schmitz, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 15, 2014
Protective role of macrophage migration inhibitory factor in nonalcoholic steatohepatitisDaniel Heinrichs, Marie-Luise Berres, Melanie Coeuru, et al.
Journal of Molecular Medicine (Berlin, Germany)|December 16, 2003
CC chemokine receptor 5 delta32 polymorphism in two independent cohorts of hepatitis C virus infected patients without hemophiliaHermann E Wasmuth, Alexa Werth, Tobias Mueller, et al.
Critical Care Medicine|June 12, 2004
Hyperglycemia at admission to the intensive care unit is associated with elevated serum concentrations of interleukin-6 and reduced ex vivo secretion of tumor necrosis factor-alphaHermann E Wasmuth, Dagmar Kunz, Jürgen Graf, et al.
Journal of Hepatology|December 17, 2008
A functional variation in CHI3L1 is associated with severity of liver fibrosis and YKL-40 serum levels in chronic hepatitis C infectionMarie-Luise Berres, Sven Papen, Katrin Pauels, et al.
Hepatology (Baltimore, Md.)|November 18, 2009
Lack of interleukin-6/glycoprotein 130/signal transducers and activators of transcription-3 signaling in hepatocytes predisposes to liver steatosis and injury in miceDaniela C Kroy, Naiara Beraza, Darjus F Tschaharganeh, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2011
Macrophage migration inhibitory factor (MIF) exerts antifibrotic effects in experimental liver fibrosis via CD74Daniel Heinrichs, Meike Knauel, Christian Offermanns, et al.
International Journal of Clinical and Experimental Pathology|April 11, 2013
Met-CCL5 modifies monocyte subpopulations during liver fibrosis regressionMiriam K Stock, Linda Hammerich, Nicole T do O, et al.
Journal of Hepatology|January 25, 2005
Patients with acute on chronic liver failure display "sepsis-like" immune paralysisHermann E Wasmuth, Dagmar Kunz, Eray Yagmur, et al.
Hepatology (Baltimore, Md.)|December 24, 2008
The Marburg I variant (G534E) of the factor VII-activating protease determines liver fibrosis in hepatitis C infection by reduced proteolysis of platelet-derived growth factor BBHermann E Wasmuth, Carmen G Tag, Eddie Van de Leur, et al.
Pageof 8

Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 6, 2011
A 7-gene signature of the recipient predicts the progression of fibrosis after liver transplantation for hepatitis C virus infectionNicole T do O, Dennis Eurich, Petra Schmitz, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 15, 2014
Protective role of macrophage migration inhibitory factor in nonalcoholic steatohepatitisDaniel Heinrichs, Marie-Luise Berres, Melanie Coeuru, et al.
Journal of Molecular Medicine (Berlin, Germany)|December 16, 2003
CC chemokine receptor 5 delta32 polymorphism in two independent cohorts of hepatitis C virus infected patients without hemophiliaHermann E Wasmuth, Alexa Werth, Tobias Mueller, et al.
Critical Care Medicine|June 12, 2004
Hyperglycemia at admission to the intensive care unit is associated with elevated serum concentrations of interleukin-6 and reduced ex vivo secretion of tumor necrosis factor-alphaHermann E Wasmuth, Dagmar Kunz, Jürgen Graf, et al.
Journal of Hepatology|December 17, 2008
A functional variation in CHI3L1 is associated with severity of liver fibrosis and YKL-40 serum levels in chronic hepatitis C infectionMarie-Luise Berres, Sven Papen, Katrin Pauels, et al.
Hepatology (Baltimore, Md.)|November 18, 2009
Lack of interleukin-6/glycoprotein 130/signal transducers and activators of transcription-3 signaling in hepatocytes predisposes to liver steatosis and injury in miceDaniela C Kroy, Naiara Beraza, Darjus F Tschaharganeh, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2011
Macrophage migration inhibitory factor (MIF) exerts antifibrotic effects in experimental liver fibrosis via CD74Daniel Heinrichs, Meike Knauel, Christian Offermanns, et al.
International Journal of Clinical and Experimental Pathology|April 11, 2013
Met-CCL5 modifies monocyte subpopulations during liver fibrosis regressionMiriam K Stock, Linda Hammerich, Nicole T do O, et al.
Journal of Hepatology|January 25, 2005
Patients with acute on chronic liver failure display "sepsis-like" immune paralysisHermann E Wasmuth, Dagmar Kunz, Eray Yagmur, et al.
Hepatology (Baltimore, Md.)|December 24, 2008
The Marburg I variant (G534E) of the factor VII-activating protease determines liver fibrosis in hepatitis C infection by reduced proteolysis of platelet-derived growth factor BBHermann E Wasmuth, Carmen G Tag, Eddie Van de Leur, et al.
Pageof 8